Manufacture

After years of speculation, we reveal what Brexit really means for pharma – so far.

And the winner of The Medicine Maker 2020 Innovation Awards is…

What is the single greatest challenge facing the cell and gene therapy industry in 2021?

Does pharma really need to pay a high price when it comes to synthetic chemistry?

High-level purification maximizes the amount of therapeutic gene payload being delivered with each vector to reduce the risk of immune reaction.

In this eBook, experts give their views on enhancing downstream purification.

Dave Tudor gives an update on CPI’s “Grand Challenges”.

DNA manufacturers must pick up the pace to support the genetic medicine revolution.

A pair of medicines manufacturing initiatives are looking to improve continuous direct compression and clinical trial supply.

How will astronauts make medicines in space?